Literature DB >> 30604051

An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use.

Alan J Budney1, Michael J Sofis2, Jacob T Borodovsky3.   

Abstract

Confusion and controversy related to the potential for cannabis use to cause harm, or alternatively to provide benefit, continues globally. This issue has grown in intensity and importance with the increased recognition of the public health implications related to the escalation of the legalization of cannabis and cannabinoid products. This selective overview and commentary attempt to succinctly convey what is known about one potential consequence of cannabis use, the development of cannabis use disorder (CUD). Such knowledge may help guide a reasonable and objective public health perspective on the potential impact of cannabis use and CUD. Current scientific data and clinical observation strongly support the contention that cannabis use, like the use of other substances such as alcohol, opioids, stimulants, and tobacco, can develop into a use disorder (addiction) with important clinical consequences. Epidemiological data indicate that the majority of those who use cannabis do not have problems related to their use, but a substantial subset (10-30%) do report experiencing symptoms and consequences consistent with a CUD. Treatment seeking for CUD comprises a substantial proportion of all substance use treatment admissions, yet treatment response rates show much room for improvement. Changing cannabis policies related to its therapeutic and recreational use are likely to impact the development of CUD and its course; however, definitive data on such effects are not yet available. Clearly, the development of more effective prevention and treatment strategies is needed for those vulnerable to developing a CUD and for those with a CUD.

Entities:  

Keywords:  Cannabis; Cannabis use disorder; Legalization; Marijuana; Policy; Prevalence; Treatment

Mesh:

Year:  2019        PMID: 30604051      PMCID: PMC6397057          DOI: 10.1007/s00406-018-0976-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  23 in total

1.  The limitations associated with measuring cannabis dependence, a response to Budney and colleagues.

Authors:  Ian Hamilton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-29       Impact factor: 5.270

Review 2.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

3.  Cannabis use and mental health: risks and benefits.

Authors:  Wayne Hall; Eva Hoch; Valentina Lorenzetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-02       Impact factor: 5.270

4.  Assessing the public health impacts of legalizing recreational cannabis use: the US experience.

Authors:  Wayne Hall; Michael Lynskey
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

5.  Assessing subjective cannabis effects in daily life with contemporary young adult language.

Authors:  Renee M Cloutier; Brian H Calhoun; Stephanie T Lanza; Ashley N Linden-Carmichael
Journal:  Drug Alcohol Depend       Date:  2021-12-01       Impact factor: 4.492

6.  How do cannabis users mentally travel in time? Evidence from an fMRI study of episodic future thinking.

Authors:  Parnian Rafei; Tara Rezapour; Seyed Amir Hossein Batouli; Antonio Verdejo-García; Valentina Lorenzetti; Javad Hatami
Journal:  Psychopharmacology (Berl)       Date:  2021-10-25       Impact factor: 4.530

7.  Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers.

Authors:  Margaret Haney; Gillinder Bedi; Ziva D Cooper; Evan S Herrmann; Stephanie Collins Reed; Richard W Foltin; Philip J Kingsley; Lawrence J Marnett; Sachin Patel
Journal:  Addict Biol       Date:  2022-07       Impact factor: 4.093

8.  Examining motivational pathways from adult attention-deficit/hyperactivity disorder symptoms to cannabis use: Results from a prospective study of veterans.

Authors:  Angela K Stevens; Rachel L Gunn; Kristina M Jackson; Brian Borsari; Jane Metrik
Journal:  Psychol Addict Behav       Date:  2020-09-03

Review 9.  The importance of psychology for shaping legal cannabis regulation.

Authors:  Jacob T Borodovsky; Michael J Sofis; Richard A Grucza; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-21       Impact factor: 3.157

10.  Investigating the Residual Effects of Chronic Cannabis Use and Abstinence on Verbal and Visuospatial Learning.

Authors:  Valentina Lorenzetti; Michael Takagi; Yvonne van Dalen; Murat Yücel; Nadia Solowij
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.